✦ LIBER ✦

Effects of the mean daily doses of imatinib during the first year on survival of patients with chronic myeloid leukemia in Japan: a study of the Hokkaido Hematology Study Group

✍ Scribed by Junichi Sugita; Junji Tanaka; Mitsutoshi Kurosawa; Takashi Fukuhara; Satoshi Hashino; Etsuhiro Torimoto; Kazuki Koizumi; Nobuo Masauji; Susumu Nishimura; Kyuhei Koda; Masahiro Imamura; Masaharu Kasai

Book ID: 114794313
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 92 KB
Volume: 0
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2007.00982.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose imatinib versus high-dose imat

High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group

✍ Noortje Thielen, Bronno van der Holt, Gregor E. G. Verhoef… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 275 KB

Fractionated doses of gemtuzumab ozogami

Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70-year old: A phase 1/2 study of the acute leukemia French association

✍ Hassan Farhat; Oumedaly Reman; Emmanuel Raffoux; Celine Berthon; Cécile Pautas; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

Variations of the ataxia telangiectasia

Variations of the ataxia telangiectasia mutated gene in patients with chronic lymphocytic leukemia lack substantial impact on progression-free survival and overall survival: a Cancer and Leukemia Group B study

✍ Lozanski, Gerard; Ruppert, Amy S.; Heerema, Nyla A.; Lozanski, Arletta; Lucas, D 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 250 KB

Consolidation with alemtuzumab in patien

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission – experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)

✍ Wendtner, C-M; Ritgen, M; Schweighofer, C D; Fingerle-Rowson, G; Campe, H; Jäger 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

5.40 Rituximab Maintenance in Patients w

5.40 Rituximab Maintenance in Patients with Chronic Lymphocytic Leukemia after First-Line Treatment with Rituximab plus Fludarabine, Cyclophosphamide, and Mitoxantrone: Final Results of a Multicenter Phase II Trial on Behalf of the Spanish CLL Study Group (GELLC)

✍ Francesc Bosch; Pau Abrisqueta; Neus Villamor; María José Terol; Eva González-Ba 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 250 KB

5.44 Consolidation Therapy with Subcutan

5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)

✍ Alain Delmer; Olivier Tournilhac; Stéphane Leprêtre; Bruno Cazin; Pierre Feugier 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 113 KB